Try our Advanced Search for more refined results
BioLineRx Ltd.
-
Response | Filed: December 06, 2023 | Entered: December 06, 2023 IN RE BIOLINERX LTD. SECURITIES LITIGATION
Securities/Commodities | New Jersey
Reply Brief to Opposition to Motion
REPLY BRIEF to Opposition to Motion filed by BIOLINERX LTD. re 33 MOTION to Dismiss (KISLIN, JASON)
-
Response | Filed: November 06, 2023 | Entered: November 06, 2023 IN RE BIOLINERX LTD. SECURITIES LITIGATION
Securities/Commodities | New Jersey
Memorandum in Opposition of Motion
MEMORANDUM in Opposition filed by PETER CATANESE, MICHAEL MORLOCK re 33 MOTION to Dismiss (Attachments: # 1 Declaration of Brenda Szydlo, # 2 Exhibit A - Chart - Alleged Materially False and Misleading Statements, # 3 Exhibit B - Compensation Policy)(PRZYBYLOWSKI, THOMAS)
-
Notice | Filed: September 26, 2023 | Entered: September 26, 2023 IN RE BIOLINERX LTD. SECURITIES LITIGATION
Securities/Commodities | New Jersey
Notice of Appearance
NOTICE of Appearance by JACLYN M. DEMAIS on behalf of BIOLINERX LTD., PHILIP A. SERLIN, MALI ZEEVI (DEMAIS, JACLYN)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login